Cross-sectional study on the prevalence of hepatic steatosis and fibrosis in patients undergoing assessment of sleep apnea

Recruiting

• Conditions: K76.0; K74.0; G47.31; Fatty (change of) liver, not elsewhere classified; Hepatic fibrosis; Mouth breathing; R06.5

• Registration Number: DRKS00024763
• Lead Sponsor: Hals-, Nasen-, Ohrenklinik und Poliklinik der Universitätsmedizin Mainz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-03-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Presence of sleep apnoea diagnosed in polygraphy or polysomnography

Exclusion Criteria

Minor
No obstructive sleep apnoea

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Retrospective evaluation of liver elasticity (in kPA) and fatty degeneration (CAP value) determined by fibroscan.

Secondary Outcome Measures

Name	Time	Method
Correlations between sleep-specific parameters (apnoea-hypopnoea index, desaturation indices, snoring index) with liver/metabolic parameters (CAP value, elasticity, abdominal circumference, body mass index) will be investigated.